Yi Ding

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction.

Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction.

Journal: Oncoimmunology

Published: May 13, 2024

HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis.

HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 14, 2023

Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells in vitro.

Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells in vitro.

Journal: Frontiers in immunology

Published: June 29, 2023

Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian Cancer.

Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian Cancer.

Journal: Cells

Published: February 16, 2022

VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients.

VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients.

Journal: PloS one

Published: August 28, 2021

Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer.

Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer.

Journal: Molecular oncology

Published: November 27, 2020

Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation.

Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation.

Journal: British journal of cancer

Published: February 28, 2019

Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients.

Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients.

Journal: Disease markers

Published: April 09, 2018

Showing 1-8 of 8

Last Updated: 09/26/2026